Oral vinorelbine and cisplatin with concurrent radiotherapy after induction chemotherapy with cisplatin and docetaxel for patients with locally advanced non-small cell lung cancer: the GFPC 05-03 study. [electronic resource]
Producer: 20110505Description: 351-7 p. digitalISSN:- 1556-1380
- Adenocarcinoma -- pathology
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Large Cell -- pathology
- Carcinoma, Non-Small-Cell Lung -- pathology
- Carcinoma, Squamous Cell -- pathology
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Docetaxel
- Female
- Follow-Up Studies
- Humans
- Lung Neoplasms -- pathology
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Staging
- Radiotherapy Dosage
- Remission Induction
- Survival Rate
- Taxoids -- administration & dosage
- Treatment Outcome
- Vinblastine -- administration & dosage
- Vinorelbine
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.